img

Global Pediatric Orphan Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Pediatric Orphan Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Pediatric orphan drugs are medications that are specifically developed and approved for the treatment of rare diseases or conditions in children. These drugs are designed to address medical needs in pediatric populations who have limited treatment options due to the rarity of their conditions. Pediatric orphan drugs are vital in addressing the unique medical needs of children with rare diseases and improving their health outcomes and quality of life.
Pediatric Orphan Drugs report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pediatric Orphan Drugs market is projected to reach US$ 102180 million in 2033, increasing from US$ 51490 million in 2022, with the CAGR of 10.5% during the period of 2023 to 2033. Demand from Hospital Pharmacies and Retail pharmacies are the major drivers for the industry.
According to our “ Pharma & Healthcare Research Center” statistics, the global sales of Orphan Drugs reached $139170 million in 2022. The North America region was the world largest Orphan Drugs market, accounting for 40% of Orphan Drugs sales in 2022, followed by Asia-Pacific. The global market for pediatric orphan drugs has been growing steadily in recent years due to increasing awareness of rare pediatric diseases, advancements in medical research and technology, and improved regulatory support for pediatric drug development.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pediatric Orphan Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Recordati SpA
Novartis
Celgene
Abbvie
Orpharma
Amgen
Amryt Pharma Plc.
Johnson & Johnson
GSK
Bristol-Myers Squibb Company
Roche Holding
Pfizer
Sanofi
Takeda
Segment by Type
Oncology Drugs
Gastrointestinal Drugs
Neurology Drugs
Cardio-vascular Drugs
Others

Segment by Application


Hospital Pharmacies
Retail pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pediatric Orphan Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pediatric Orphan Drugs introduction, etc. Pediatric Orphan Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Pediatric Orphan Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Pediatric Orphan Drugs
1.1 Pediatric Orphan Drugs Market Overview
1.1.1 Pediatric Orphan Drugs Product Scope
1.1.2 Pediatric Orphan Drugs Market Status and Outlook
1.2 Global Pediatric Orphan Drugs Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Pediatric Orphan Drugs Market Size by Region (2018-2033)
1.4 Global Pediatric Orphan Drugs Historic Market Size by Region (2018-2023)
1.5 Global Pediatric Orphan Drugs Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Pediatric Orphan Drugs Market Size (2018-2033)
1.6.1 North America Pediatric Orphan Drugs Market Size (2018-2033)
1.6.2 Europe Pediatric Orphan Drugs Market Size (2018-2033)
1.6.3 Asia-Pacific Pediatric Orphan Drugs Market Size (2018-2033)
1.6.4 Latin America Pediatric Orphan Drugs Market Size (2018-2033)
1.6.5 Middle East & Africa Pediatric Orphan Drugs Market Size (2018-2033)
2 Pediatric Orphan Drugs Market by Type
2.1 Introduction
2.1.1 Oncology Drugs
2.1.2 Gastrointestinal Drugs
2.1.3 Neurology Drugs
2.1.4 Cardio-vascular Drugs
2.1.5 Others
2.2 Global Pediatric Orphan Drugs Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Pediatric Orphan Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Pediatric Orphan Drugs Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Pediatric Orphan Drugs Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Pediatric Orphan Drugs Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Pediatric Orphan Drugs Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Pediatric Orphan Drugs Revenue Breakdown by Type (2018-2033)
3 Pediatric Orphan Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail pharmacies
3.1.3 Others
3.2 Global Pediatric Orphan Drugs Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Pediatric Orphan Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Pediatric Orphan Drugs Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Pediatric Orphan Drugs Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Pediatric Orphan Drugs Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Pediatric Orphan Drugs Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Pediatric Orphan Drugs Revenue Breakdown by Application (2018-2033)
4 Pediatric Orphan Drugs Competition Analysis by Players
4.1 Global Pediatric Orphan Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)
4.3 Date of Key Players Enter into Pediatric Orphan Drugs Market
4.4 Global Top Players Pediatric Orphan Drugs Headquarters and Area Served
4.5 Key Players Pediatric Orphan Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Pediatric Orphan Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Recordati SpA
5.1.1 Recordati SpA Profile
5.1.2 Recordati SpA Main Business
5.1.3 Recordati SpA Pediatric Orphan Drugs Products, Services and Solutions
5.1.4 Recordati SpA Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Recordati SpA Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Pediatric Orphan Drugs Products, Services and Solutions
5.2.4 Novartis Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Celgene
5.3.1 Celgene Profile
5.3.2 Celgene Main Business
5.3.3 Celgene Pediatric Orphan Drugs Products, Services and Solutions
5.3.4 Celgene Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Abbvie Recent Developments
5.4 Abbvie
5.4.1 Abbvie Profile
5.4.2 Abbvie Main Business
5.4.3 Abbvie Pediatric Orphan Drugs Products, Services and Solutions
5.4.4 Abbvie Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Abbvie Recent Developments
5.5 Orpharma
5.5.1 Orpharma Profile
5.5.2 Orpharma Main Business
5.5.3 Orpharma Pediatric Orphan Drugs Products, Services and Solutions
5.5.4 Orpharma Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Orpharma Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Pediatric Orphan Drugs Products, Services and Solutions
5.6.4 Amgen Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Amryt Pharma Plc.
5.7.1 Amryt Pharma Plc. Profile
5.7.2 Amryt Pharma Plc. Main Business
5.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Products, Services and Solutions
5.7.4 Amryt Pharma Plc. Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Amryt Pharma Plc. Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson Pediatric Orphan Drugs Products, Services and Solutions
5.8.4 Johnson & Johnson Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
5.9 GSK
5.9.1 GSK Profile
5.9.2 GSK Main Business
5.9.3 GSK Pediatric Orphan Drugs Products, Services and Solutions
5.9.4 GSK Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 GSK Recent Developments
5.10 Bristol-Myers Squibb Company
5.10.1 Bristol-Myers Squibb Company Profile
5.10.2 Bristol-Myers Squibb Company Main Business
5.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Products, Services and Solutions
5.10.4 Bristol-Myers Squibb Company Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Bristol-Myers Squibb Company Recent Developments
5.11 Roche Holding
5.11.1 Roche Holding Profile
5.11.2 Roche Holding Main Business
5.11.3 Roche Holding Pediatric Orphan Drugs Products, Services and Solutions
5.11.4 Roche Holding Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Roche Holding Recent Developments
5.12 Pfizer
5.12.1 Pfizer Profile
5.12.2 Pfizer Main Business
5.12.3 Pfizer Pediatric Orphan Drugs Products, Services and Solutions
5.12.4 Pfizer Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.12.5 Pfizer Recent Developments
5.13 Sanofi
5.13.1 Sanofi Profile
5.13.2 Sanofi Main Business
5.13.3 Sanofi Pediatric Orphan Drugs Products, Services and Solutions
5.13.4 Sanofi Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.13.5 Sanofi Recent Developments
5.14 Takeda
5.14.1 Takeda Profile
5.14.2 Takeda Main Business
5.14.3 Takeda Pediatric Orphan Drugs Products, Services and Solutions
5.14.4 Takeda Pediatric Orphan Drugs Revenue (US$ Million) & (2018-2023)
5.14.5 Takeda Recent Developments
6 North America
6.1 North America Pediatric Orphan Drugs Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Pediatric Orphan Drugs Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pediatric Orphan Drugs Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pediatric Orphan Drugs Market Dynamics
11.1 Pediatric Orphan Drugs Industry Trends
11.2 Pediatric Orphan Drugs Market Drivers
11.3 Pediatric Orphan Drugs Market Challenges
11.4 Pediatric Orphan Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Pediatric Orphan Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Pediatric Orphan Drugs Market Size Share by Region (2018-2023)
Table 4. Global Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Pediatric Orphan Drugs Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Pediatric Orphan Drugs Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Pediatric Orphan Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Pediatric Orphan Drugs Revenue Market Share by Type (2024-2033)
Table 11. North America Pediatric Orphan Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Pediatric Orphan Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Pediatric Orphan Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Pediatric Orphan Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Pediatric Orphan Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Pediatric Orphan Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Pediatric Orphan Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Pediatric Orphan Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Pediatric Orphan Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Pediatric Orphan Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Pediatric Orphan Drugs Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Pediatric Orphan Drugs Revenue Market Share by Application (2018-2023)
Table 24. Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Pediatric Orphan Drugs Revenue Market Share by Application (2024-2033)
Table 26. North America Pediatric Orphan Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Pediatric Orphan Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Pediatric Orphan Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Pediatric Orphan Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Pediatric Orphan Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Pediatric Orphan Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Pediatric Orphan Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Pediatric Orphan Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Pediatric Orphan Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Pediatric Orphan Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Pediatric Orphan Drugs Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Pediatric Orphan Drugs Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)
Table 39. Date of Key Players Enter into Pediatric Orphan Drugs Market
Table 40. Global Pediatric Orphan Drugs Key Players Headquarters and Area Served
Table 41. Pediatric Orphan Drugs Product Solution and Service
Table 42. Global Pediatric Orphan Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Recordati SpA Basic Information List
Table 45. Recordati SpA Description and Business Overview
Table 46. Recordati SpA Pediatric Orphan Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Recordati SpA (2018-2023)
Table 48. Recordati SpA Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Pediatric Orphan Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Novartis (2018-2023)
Table 53. Novartis Recent Developments
Table 54. Celgene Basic Information List
Table 55. Celgene Description and Business Overview
Table 56. Celgene Pediatric Orphan Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Celgene (2018-2023)
Table 58. Celgene Recent Developments
Table 59. Abbvie Basic Information List
Table 60. Abbvie Description and Business Overview
Table 61. Abbvie Pediatric Orphan Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Abbvie (2018-2023)
Table 63. Abbvie Recent Developments
Table 64. Orpharma Basic Information List
Table 65. Orpharma Description and Business Overview
Table 66. Orpharma Pediatric Orphan Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Orpharma (2018-2023)
Table 68. Orpharma Recent Developments
Table 69. Amgen Basic Information List
Table 70. Amgen Description and Business Overview
Table 71. Amgen Pediatric Orphan Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Amgen (2018-2023)
Table 73. Amgen Recent Developments
Table 74. Amryt Pharma Plc. Basic Information List
Table 75. Amryt Pharma Plc. Description and Business Overview
Table 76. Amryt Pharma Plc. Pediatric Orphan Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Amryt Pharma Plc. (2018-2023)
Table 78. Amryt Pharma Plc. Recent Developments
Table 79. Johnson & Johnson Basic Information List
Table 80. Johnson & Johnson Description and Business Overview
Table 81. Johnson & Johnson Pediatric Orphan Drugs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Johnson & Johnson (2018-2023)
Table 83. Johnson & Johnson Recent Developments
Table 84. GSK Basic Information List
Table 85. GSK Description and Business Overview
Table 86. GSK Pediatric Orphan Drugs Products, Services and Solutions
Table 87. Revenue (US$ Million) in Pediatric Orphan Drugs Business of GSK (2018-2023)
Table 88. GSK Recent Developments
Table 89. Bristol-Myers Squibb Company Basic Information List
Table 90. Bristol-Myers Squibb Company Description and Business Overview
Table 91. Bristol-Myers Squibb Company Pediatric Orphan Drugs Products, Services and Solutions
Table 92. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Bristol-Myers Squibb Company (2018-2023)
Table 93. Bristol-Myers Squibb Company Recent Developments
Table 94. Roche Holding Basic Information List
Table 95. Roche Holding Description and Business Overview
Table 96. Roche Holding Pediatric Orphan Drugs Products, Services and Solutions
Table 97. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Roche Holding (2018-2023)
Table 98. Roche Holding Recent Developments
Table 99. Pfizer Basic Information List
Table 100. Pfizer Description and Business Overview
Table 101. Pfizer Pediatric Orphan Drugs Products, Services and Solutions
Table 102. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Pfizer (2018-2023)
Table 103. Pfizer Recent Developments
Table 104. Sanofi Basic Information List
Table 105. Sanofi Description and Business Overview
Table 106. Sanofi Pediatric Orphan Drugs Products, Services and Solutions
Table 107. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Sanofi (2018-2023)
Table 108. Sanofi Recent Developments
Table 109. Takeda Basic Information List
Table 110. Takeda Description and Business Overview
Table 111. Takeda Pediatric Orphan Drugs Products, Services and Solutions
Table 112. Revenue (US$ Million) in Pediatric Orphan Drugs Business of Takeda (2018-2023)
Table 113. Takeda Recent Developments
Table 114. North America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 115. North America Pediatric Orphan Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 116. Europe Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 117. Europe Pediatric Orphan Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 118. Asia-Pacific Pediatric Orphan Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 119. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 120. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 121. Asia-Pacific Pediatric Orphan Drugs Market Share by Region (2018-2023)
Table 122. Asia-Pacific Pediatric Orphan Drugs Market Share by Region (2024-2033)
Table 123. Latin America Pediatric Orphan Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 124. Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 125. Latin America Pediatric Orphan Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 126. Middle East & Africa Pediatric Orphan Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 127. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 128. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 129. Pediatric Orphan Drugs Market Trends
Table 130. Pediatric Orphan Drugs Market Drivers
Table 131. Pediatric Orphan Drugs Market Challenges
Table 132. Pediatric Orphan Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Orphan Drugs Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Pediatric Orphan Drugs Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Pediatric Orphan Drugs Market Share by Regions: 2022 VS 2033
Figure 4. Global Pediatric Orphan Drugs Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Pediatric Orphan Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Pediatric Orphan Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Pediatric Orphan Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Pediatric Orphan Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Pediatric Orphan Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Oncology Drugs
Figure 11. Global Oncology Drugs Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Gastrointestinal Drugs
Figure 13. Global Gastrointestinal Drugs Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Neurology Drugs
Figure 15. Global Neurology Drugs Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Cardio-vascular Drugs
Figure 17. Global Cardio-vascular Drugs Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Global Pediatric Orphan Drugs Market Size Share by Type: 2022 & 2033
Figure 21. North America Pediatric Orphan Drugs Revenue Market Share by Type (2018-2033)
Figure 22. Europe Pediatric Orphan Drugs Revenue Market Share by Type (2018-2033)
Figure 23. Asia-Pacific Pediatric Orphan Drugs Revenue Market Share by Type (2018-2033)
Figure 24. Latin America Pediatric Orphan Drugs Revenue Market Share by Type (2018-2033)
Figure 25. Middle East and Africa Pediatric Orphan Drugs Revenue Market Share by Type (2018-2033)
Figure 26. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Retail pharmacies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 29. Global Pediatric Orphan Drugs Market Size Share by Application: 2022 & 2033
Figure 30. North America Pediatric Orphan Drugs Revenue Market Share by Application (2018-2033)
Figure 31. Europe Pediatric Orphan Drugs Revenue Market Share by Application (2018-2033)
Figure 32. Asia-Pacific Pediatric Orphan Drugs Revenue Market Share by Application (2018-2033)
Figure 33. Latin America Pediatric Orphan Drugs Revenue Market Share by Application (2018-2033)
Figure 34. Middle East and Africa Pediatric Orphan Drugs Revenue Market Share by Application (2018-2033)
Figure 35. Pediatric Orphan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Pediatric Orphan Drugs Market Share in 2022
Figure 37. North America Pediatric Orphan Drugs Market Share by Country (2018-2033)
Figure 38. United States Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 39. Canada Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 40. Germany Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 41. France Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 42. U.K. Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 43. Italy Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 44. Russia Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 45. Nordic Countries Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 46. Asia-Pacific Pediatric Orphan Drugs Market Share by Region (2018-2033)
Figure 47. China Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 48. Japan Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 49. South Korea Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 51. India Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 52. Australia Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 53. Latin America Pediatric Orphan Drugs Market Share by Country (2018-2033)
Figure 54. Mexico Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 55. Brazil Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 56. Middle East & Africa Pediatric Orphan Drugs Market Share by Country (2018-2033)
Figure 57. Turkey Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 59. UAE Pediatric Orphan Drugs Market Size (2018-2033) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report